Cargando…

C5 Inhibition in Secondary Thrombotic Microangiopathies: A Yet Unresolved Question

Detalles Bibliográficos
Autores principales:	Werion, Alexis, Rondeau, Eric
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8071650/ https://www.ncbi.nlm.nih.gov/pubmed/33939775 http://dx.doi.org/10.1016/j.ekir.2021.02.012

Ejemplares similares

Application of C5 inhibitors in glomerular diseases in 2021
por: Werion, Alexis, et al.
Publicado: (2022)

Genetic screening in thrombotic microangiopathy: a plea for methylmalonic aciduria with cobalamine C deficiency detection
por: Rafat, Cédric, et al.
Publicado: (2023)

Direct or indirect endothelial damage? An unresolved question
por: Basta, Giuseppina
Publicado: (2021)

Complement in Secondary Thrombotic Microangiopathy
por: Palma, Lilian Monteiro Pereira, et al.
Publicado: (2020)

Severe hypertension and (renal) thrombotic microangiopathy: solving the puzzle
por: Wehrmann, Florian, et al.
Publicado: (2023)

Complement C5 inhibition reverses bleomycin-induced thrombotic microangiopathy
por: Salhi, Sofiane, et al.
Publicado: (2020)

Aromatase inhibitors as adjuvant therapy for postmenopausal women: a therapeutic advance but many unresolved questions
por: Ligibel, Jennifer A, et al.
Publicado: (2005)

Thrombotic microangiopathy secondary to recurrent prostate cancer
por: Newton, Joseph, et al.
Publicado: (2021)

Evidence for secondary thrombotic microangiopathy in COVID-19
por: Sweeney, Joseph M., et al.
Publicado: (2020)

Thrombotic Microangiopathies
por: Radhi, Mohamed, et al.
Publicado: (2012)

The thrombotic microangiopathies
por: Copelovitch, Lawrence, et al.
Publicado: (2008)

Functional and Genetic Landscape of Complement Dysregulation Along the Spectrum of Thrombotic Microangiopathy and its Potential Implications on Clinical Outcomes
por: Timmermans, Sjoerd A.M.E.G., et al.
Publicado: (2021)

A Case of Thrombotic Microangiopathy Secondary to Hypertensive Emergency
por: Bandaru, Sai Samyuktha, et al.
Publicado: (2022)

Thrombotic Microangiopathy Secondary to Pancreatitis: A Diagnostic Enigma
por: Bagai, Sahil, et al.
Publicado: (2022)

Thrombotic Microangiopathy Secondary to Intravenous Abuse of Opana® ER
por: Thakur, Kamia, et al.
Publicado: (2017)

Complement C5-inhibiting therapy for the thrombotic microangiopathies: accumulating evidence, but not a panacea
por: Brocklebank, Vicky, et al.
Publicado: (2017)

Thrombotic microangiopathy in children
por: Palma, Lilian Monteiro P., et al.
Publicado: (2022)

Microangiopathy in multiple myeloma: a case of carfilzomib-induced secondary thrombotic microangiopathy successfully treated with plasma exchange and complement inhibition
por: Catanese, Lorenzo, et al.
Publicado: (2023)

Pseudo-Thrombotic Microangiopathy Secondary to Vitamin B12 Deficiency
por: Morrissey, Dylan, et al.
Publicado: (2022)

C5 inhibition allows continued antineoplastic therapy in cancer- and chemotherapy-associated thrombotic microangiopathy
por: Shah, Hridaya, et al.
Publicado: (2022)

Eculizumab in gemcitabine-induced thrombotic microangiopathy: experience of the French thrombotic microangiopathies reference centre
por: Grall, Maximilien, et al.
Publicado: (2021)

An updated classification of thrombotic microangiopathies and treatment of complement gene variant-mediated thrombotic microangiopathy
por: Aigner, Christof, et al.
Publicado: (2019)

Propagation of alpha-synuclein pathology: hypotheses, discoveries, and yet unresolved questions from experimental and human brain studies
por: Uchihara, Toshiki, et al.
Publicado: (2015)

The Formidable yet Unresolved Interplay between Endometriosis and Obesity
por: Pantelis, Athanasios, et al.
Publicado: (2021)

COVID-19 and thrombotic microangiopathies
por: Tiwari, Nishant R., et al.
Publicado: (2021)

Thrombotic microangiopathy triggered by podocytopathy
por: Veríssimo, Rita, et al.
Publicado: (2021)

Thrombotic microangiopathy in juvenile dermatomyositis
por: Frolenko, A, et al.
Publicado: (2011)

Thrombotic microangiopathy in renal allografts
por: Radha, S., et al.
Publicado: (2014)

Influenza-associated thrombotic microangiopathies
por: Bitzan, Martin, et al.
Publicado: (2017)

Acyclovir-induced thrombotic microangiopathy
por: Goli, R., et al.
Publicado: (2017)

Cancer-associated thrombotic microangiopathy
por: Govind Babu, K, et al.
Publicado: (2016)

Thrombotic Microangiopathy Syndrome in the ICU
por: Samy Modeliar, S., et al.
Publicado: (2006)

Thrombotic Microangiopathy Syndrome in the ICU
por: Samy Modeliar, S., et al.
Publicado: (2006)

Thrombotic microangiopathies: An illustrated review
por: Abou‐Ismail, Mouhamed Yazan, et al.
Publicado: (2022)

Diagnosis and treatment of thrombotic microangiopathy
por: Thompson, Gemma L., et al.
Publicado: (2022)

Chemotherapy-Associated Thrombotic Microangiopathy
por: Aklilu, Abinet M., et al.
Publicado: (2023)

Role of C5 inhibition in Idiopathic Inflammatory Myopathies and Scleroderma Renal Crisis–Induced Thrombotic Microangiopathies
por: Gouin, Anna, et al.
Publicado: (2021)

Unresolved questions in the zoonotic transmission of MERS
por: Peiris, Malik, et al.
Publicado: (2022)

Eculizumab for Severe Thrombotic Microangiopathy Secondary to Surgical Invasive Stress and Bleeding
por: Fujita, Yoko, et al.
Publicado: (2020)

C-Peptide as a Remedy for Diabetic Microangiopathy?
por: Waldhäusl, Werner
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_2u4e4usr2somq1clvt123c2sdg